Substantia nigra: The involvement of central and peripheral benzodiazepine receptors in physical dependence on diazepam as evidenced by behavioral and EEG effects

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 611-623

  Wala, Elzbieta P ^a   Sloan, Jewell W ^a   Jing, Xin ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Central benzodiazepine receptors; EEG; Flumazenil; Focal injection; Peripheral benzodiazepine receptors; PK 11195; Precipitated withdrawal; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; DIAZEPAM; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

ANIMALS; ANTI-ANXIETY AGENTS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; FLUMAZENIL; GABA MODULATORS; ISOQUINOLINES; MALE; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SUBSTANTIA NIGRA; WEIGHT GAIN;

EID: 0032879005     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00125-2     Document Type: Article

References (84)

1. Aley K.O., Kulkarni S.K. Effect of chronic treatment of Ro 15-1788 and its withdrawal on cortical and hippocampal EEG activity in rats. Indian J. Exp. Biol. 28:1990;1149-1159.
2. 3H] PK 11195, an isoquinoline carboxamide derivetive. Kinetic studies and autoradiographic localization J. Neurochem. 41:1983;1744-1750.
3. 3H]flumazenil binding in the rat central nervous system. J. Pharmacol. Exp. Ther. 263:1992;884-896.
4. Braestrup C., Squires R.F. Pharmacological characteristics of benzodiazepine receptors in the brain. Eur. J. Pharmacol. 48:1978;263-270.
5. Breimer L.T., Burm A.G., Danhof M., Hennis P.J., Vletter A.A., de Voogt J.H.D., Spierdijk J., Bovill J.G. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis. Clin. Pharmacokinet. 20:1991;497-508.
6. Byrnes, J. J.; Miller, L. G.; Perkins, K.; Greenblatt, D. J.; Shader, R. I. Chronic benzodiazepine administration XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects. Neuropsychopharmacology 8:267-273; 1993.
7. Coenen A.M., van Luijtelaar E.L. Effects of diazepam and two beta-carbolines on epileptic activity and on EEG and behavior in rats with absence seizures. Pharmacol. Biochem. Behav. 32:1989;27-35.
8. Costa E., Auta J., Caruncho H, Guidotti A., Impagnatiello F., Pesod C., Thompson D.M. A search for a new anticonvulsant and anxiolitic benzodiazepine devoid of side effects and tolerance liability. Biggio G., Sanna E., Costa E. Receptors and anxiety. From neurobiology to treatment:1995;75-92 Raven Press, New York.
9. Criswell H.E., Simson P.E., Knapp D.J., Devaud L.L., McCown T.J., Duncan G.E., Morrow A.L., Breese G.R. Effect of zolpidem on γ-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several rat brain regions. J. Pharmacol. Exp. Ther. 273:1995;526-536.
10. Cymerman U., Pazos A., Palacios J.M. Evidence for species differences in "peripheral" benzodiazepine receptors. An autoradiographic study Neurosci. Lett. 66:1986;153-158.
11. Fallon J.H., Loughlin S.E. Substantia nigra. Paxinos G. The rat nervous system. 1995;215-237 Academic Press, San Diego.
12. File S.E., Pellow S. The effects of PK11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress. Pharmacol. Biochem. Behav. 23:1985;737-741.
13. File S.E., Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berlin). 88:1986;1-11.
14. Fiset P., Lemmens H.L., Egan T.E., Shafer S.L., Stanski D.R. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin. Pharmacol. Ther. 58:1995;567-582.
15. Fritschy J.M., Benke D., Mertens S., Oertel W.H., Bachi T., Mohler H. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl. Acad. Sci. USA. 89:1992;6726-6730.
16. Gallager D.W., Malcolm A.B., Anderson S.A., Gonsalves S.F. Continuous release of diazepam. Electrophysiological, biochemical and behavioral consequences Brain Res. 342:1985;26-36.
17. 35S]t-butylbicyclophosphorothionate binding to a chloride ionosphore in rat brain via a novel Ro5 4864 binding site. J. Pharmacol. Exp. Ther. 240:1987;747-753.
18. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., McEwen B.S. Steroid modulation of the chloride ionophore in rat brain. Structure-activity requirements, regional dependence and mechanism of action J. Pharmacol. Exp. Ther. 246:1988;803-812.
19. Gobbi M., Barone D., Mennini T., Garatini S. Diazepam and desmethyldiazepam differ in their affinities and efficacies at "central" and "peripheral" benzodiazepine receptors. J. Pharm. Pharmacol. 39:1987;388-391.
20. Hallstrom C., Lader M. Benzodiazepine withdrawal phenomena. Int. Pharmacopsychiatr. 16:1981;235-244.
21. Hertz L. Binding characteristics of the receptor and coupling to transport proteins. Giesen-Crouse E. Peripheral benzodiazepine receptors. 1993;27-59 Academic Press, London.
22. Iwaya N., Morita Y., Miyoshi K. Determination of pharmacodynamics of diazepam by quantitative pharmaco-EEG. Jpn. J. Psychiatr. Neurol. 43:1989;675-684.
23. Jing X., Wala E.P., Sloan J.W. Flunitrazepam and nordiazepam slowly released from silastic capsules induce physical dependence in rat. Drug Alcohol Depend. 39:1995;63-67.
24. Jing X., Sloan J.W., Wala E.P. Physical dependence on oxazepam in rats. Res. Commun. Alcohol Subst. Abuse. 18:1997;31-46.
25. Kuhlmann A.C., Guilarte T.R. The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity. Brain Res. 751:1997;281-288.
26. A receptors. J. Neurochem. 64:1995;684-688.
27. Lee M.G., Park E.J., Kim S.K. Pharmacologic interactions of diazepam and flumazenil on cortical EEG and behavior in rats. Soc. Neurosci. Abstr. 23:1997;949.
28. Lister R.G., Greenblatt D.J., Abernathy D.R., File S.E. Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res. 290:1984;183-186.
29. Longo V.G., Massotti M., DeMedici D., Valerio A. Modifications of brain electrical activity after activation of the benzodiazepine receptor types in rats and rabbits. Pharmacol. Biochem. Behav. 29:1988;785-790.
30. Loscher W., Ebert U., Lehmann H., Rosenthal C., Nikkhah G. Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. Soc. Neurosci. Abstr. 22:1996;1655.
31. Mandema J.W., Sansom L.N., Dios-Vieitez M.C., Hollander-Jansen M., Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. J. Pharmacol. Exp. Ther. 257:1991;472-478.
32. Mandema J.W., Danhof M. Electroencephologram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin. Pharmacokinet. 23:1992;191-215.
33. Mandema J.W., Kuck M.T., Danhof M. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. Br. J. Pharmacol. 105:1992;164-170.
34. Mandema J.W., Kuck M.T., Danhof M. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy. J. Pharmacol. Exp. Ther. 261:1992;56-61.
35. Mandema J.W., Tukker E., Danhof M. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist. midazolam and flumazenil J. Pharmacol. Exp. Ther. 260:1992;36-44.
36. Manmaru S., Matsuura M. Two kinds of spatiotemporal EEG changes after discontinuation of benzodiazepine, medazepam. Jpn. J. Psychiatr. Neurol. 44:1990;85-90.
37. Marescaux C., Micheletti G., Vergnes M., Depaulis A., Rumbach L., Warter J. Biphasic effects of Ro 15-1788 on spontaneous petit mal-like seizures in rats. Eur. J. Pharmacol. 102:1984;335-359.
38. Martin W.R., Sloan J.W., Wala E. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs. J. Pharmacol. Exp. Ther. 255:1990;744-755.
39. Martin W.R., Sloan J.W., Wala E.P. Precipitated abstinence in the diazepam-dependent rat. Pharmacol. Biochem. Behav. 46:1993;683-688.
40. Martinez J.A., Fargeas M.J., Bueno L. Physical dependence on diazepam. Precipitation of abstinence syndromes by peripheral and central benzodiazepine receptor antagonists Pharmacol. Biochem. Behav. 41:1992;461-464.
41. 3) in the tolerance to the electroencephalographic efftects of benzodiazepines in rats. Comparison of diazepam and clonazepam Pharmacol. Biochem. Behav. 35:1990;933-936.
42. McCabe R.T., Wamsley J.K. Autoradiographic localization of subcomponents of the macromolecular GABA receptor complex. Life Sci. 39:1986;1937-1945.
43. Mele L., Sagratella S., Massotti M. Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro. Brain Res. 323:1984;93-102.
44. A receptors and anxiety. From neurobiology to treatment:1995;17-40 Raven Press, New York.
45. Miller L.G., Galpern W.R., Byrnes J.J., Greenblatt D.J., Shader R.I. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK 11195 attentuates chronic effects of lorazepam. J. Pharmacol. Exp. Ther. 261:1992;285-289.
46. A -receptor subtypes in vivo: Cellular localization, pharmacology and regulation. In: Biggio G.; Sanna, E.; Costa, E. eds. Receptors and anxiety: From neurobiology to treatment. New York: Raven Press; 1995:75-92.
47. Mohler H., Burkard W.P., Keller H.H., Richards J.G., Haefely G. Benzodiazepine antagonist Ro 15-1788. Binding characteristics and interation with drug-induced changes in dopamine turnover and cerebellar cGMP levels J. Neurochem. 37:1981;714-722.
48. Mohler H., Okada T. Benzodiazepine receptor. Demonstration in the central nervous system Science. 198:1977;849-851.
49. Murayama T., Shingu K., Ogawa T., Tomoda K., Shindo K., Tamai S., Mori K. Flumazenil does not antagonize halothane, thiamylal or propofol anaesthesia in rats. Br. J. Anesthesiol. 69:1992;61-64.
50. Nakamoto Y., Watabe S., Shiotani T., Yoshii M. Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice. Brain Res. 717:1996;91-98.
51. Nickel B., Szelenyi I. Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam. Neuropharmacology. 28:1989;799-803.
52. 3H] Flunitrazepam binding sites J. Neurochem. 49:1987;890-899.
53. A receptors. FASEB J. 4:1990;1469-1480.
54. Pazos A., Cymerman U., Probst A., Palacios J.M. Peripheral benzodiazepine binding sites in human brain and kidney. Autoradiographic studies Neurosci. Lett. 66:1986;147-152.
55. A receptor subunits in the rat CNS. J. Comp. Neurol. 326:1992;193-216.
56. Petursson H., Lader M.H. Withdrawal from long-term benzodiazepine treatment. Br. Med. J. 283:1981;643-645.
57. Ramsey V.A., Tietz E.I., Rosenberg H.C. Chronic flurazepam differentially regulates a behavioral effect of GABA agonists. Pharmacol. Biochem. Behav. 38:1991;659-663.
58. Ross R.J., Waszczak B.L., Lee E.K., Walters J.R. Effects of benzodiazepines on single unit activity in the substantia nigra pars reticulata. Life Sci. 31:1982;1025-1035.
59. A /benzodiazepine receptor complex in the rat nervous system. J Neurochem. 64:1992;867-873.
60. Saano V., Rago L., Raty M. Peripheral benzodiazepine binding sites. Pharmacol. Ther. 41:1989;503-514.
61. Santucci V., Fournier M., Worms P., Keane P., Biziere K. Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 340:1989;93-100.
62. Sloan J.W., Wala E.P., Jing X., Holtman P.H. Effect of gender on physical dependence on diazepam (DZ) in rats. Soc. Neurosci. Abstr. 22:1996;2075.
63. Sloan J.W., Wala E.P., Jing X. PK 11195 (PK)-evoked withdrawal in diazepam (DZ)-dependent rats. Effect of dose of PK, DZ and gender Soc. Neurosci. Abstr. 23:1997;2392.
64. Sloan J.W., Wala E.P., Jing X. Regional CNS heterogeneities in flumazenil-precipitated withdrawal in diazepam-dependent female rats. FASEB J. 12:1998;161.
65. Sloan J.W., Wala E.P., Jing X. Effect of repeated (daily vs weekly) administration of PK 11195 on precipitated withdrawal scores in diazepam-dependent male and female rats. Soc. Neurosci. Abstr. 24:1998;196.
66. Sloan J.W., Wala E., Jing X., Holtman J.R., Milliken B. Diazepam-treated female rats. Flumazenil- and PK 11195-induced withdrawal in the hippocampus CA1 Pharmacol. Biochem. Behav. 60:1998;1-10.
67. Tietz E.I., Rosenberg H.C. Behavioral measurement of benzodiazepine tolerance and GABAergic subsensitivity in the substantia nigra pars reticulata. Brain Res. 438:1988;41-51.
68. Tietz E.I., Rosenberg H.C., Chiu T.H. Autoradiographic localization of benzodiazepine receptor downregulation. J. Pharmacol. Exp. Ther. 236:1986;284-292.
69. Tyma J.L., Rosenberg H.C., Tietz E.I., Chiu T.H. Effects of chronic flurazepam treatment on firing rate of rat substantia nigra pars reticulata neurons. Brain Res. 453:1988;344-348.
70. Valerio A., Massotti M. Electroencephalographic changes after short-term exposure to agonists of benzodiazepine receptors in the rat. Pharmacol. Biochem. Behav. 29:1988;791-795.
71. Villiger J.W. Characterization of peripheral-type benzodiazepine recognition sites in the rat spinal cord. Neuropharmacology. 24:1985;95-98.
72. Wala E.P., Sloan J.W., Jing X., Holtman P.H. Intrathecally administered flumazenil and PK 11195 precipitate abstinence syndrome in freely moving diazepam dependent rats. Drug Alcohol Depend. 43:1996;169-177.
73. Wala E.P., Sloan J.W., Jing X. Dorsal raphe and substantia nigra response to flumazenil in diazepam-dependent rats. Pharmacol. Biochem. Behav. 58:1997;221-229.
74. Wala E.P., Sloan J.W., Jing X. Comparison of abstinence syndromes precipitated by flumazenil and PK 11195 in female diazepam-dependent rats. Psychopharmacology (Berlin). 133:1997;214-223.
75. Waszczak B.L., Lee E.K., Walters J.R. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons. J. Pharmacol. Exp. Ther. 239:1986;601-611.
76. Wilson M.A. Divergent alterations in γ-aminobutyric acid/benzodiazepine responses of male and ovariectomized rats after chronic benzodiazepine agonist exposure. Electrophysiological analysis of substantia nigra pars reticulata neurons J. Pharmacol. Exp. Ther. 266:1993;774-779.
77. Wilson M.A. Gonadectomy and sex modulate spontaneous activity of substantia nigra pars reticulata neurons without modifying GABA/benzodiazepine responsiveness. Life Sci. 53:1993;217-225.
78. Wilson M.A., Gallager D.W. Effects of chronic diazepam exposure on GABA sensitivity and on benzodiazepine potentiation of GABA-mediated responses of substantia nigra pars reticulata neurons of rats. Eur. J Pharmacol. 136:1987;333-343.
79. Wilson M.A., Gallager D.W. Ro 15-1788-induced seizures in rats continually exposed to diazepam for prolonged periods. Epilepsy Res. 2:1988;14-19.
80. Wilson M.A., Gallager D.W. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of γ-aminobutyric acid sensitivity. J. Pharmacol. Exp. Ther. 248:1989;879-885.
81. Wilson M.A., Gallager D.W. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate. J. Pharmacol. Exp. Ther. 248:1989;886-891.
82. Woods J.H., Katz J.L., Winger G. Benzodiazepines. Use, abuse and consequences Pharmacol. Rev. 44:1992;169-189.
83. Young W.S., Niehoff D., Kuhar M.J., Beer B., Lippa A.S. Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. J. Pharmacol. Exp. Ther. 216:1981;425-430.
84. Zhang H., Rosenberg H.C., Tietz E.I. Injection of benzodiazepines but not GABA or muscimol into pars reticulata of substantia nigra suppresses pentylenetetrazol. Brain Res. 488:1989;73-79.